MAIN ALAN J
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to MAIN ALAN J. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LXRX | EVP, Innov & Chem Sciences | Option Exercise | 25,667 | — | — | Feb 28, 2025 |
| LXRX | EVP, Innov & Chem Sciences | Option Exercise | 25,666 | — | — | Feb 28, 2024 |
| LXRX | EVP, Innov & Chem Sciences | Option Exercise | 25,667 | — | — | Feb 28, 2023 |
| LXRX | EVP, Innov & Chem Sciences | Tax Withholding | 19,756 | $2.85 | $56,305 | Feb 28, 2022 |
| LXRX | EVP, Innov & Chem Sciences | Option Exercise | 23,300 | — | — | Feb 28, 2021 |
| LXRX | EVP, Commercial Supply Ops | Tax Withholding | 6,813 | $1.96 | $13,353 | Apr 22, 2020 |
| LXRX | EVP, Commercial Supply Ops | Option Exercise | 22,373 | — | — | Feb 28, 2020 |
| LXRX | EVP, Commercial Supply Ops | Option Exercise | 2,498 | — | — | Feb 28, 2019 |
| LXRX | EVP, Commercial Supply Ops | Tax Withholding | 4,962 | $8.53 | $42,326 | Feb 28, 2018 |
| LXRX | EVP, CMC and Supply Operations | Option Exercise | 2,678 | — | — | Feb 28, 2017 |
| LXRX | EVP, CMC and Supply Operations | Tax Withholding | 4,754 | $9.07 | $43,119 | Feb 29, 2016 |
| LXRX | EVP, CMC and Supply Operations | Option Exercise | 16,250 | — | — | Mar 2, 2015 |
| LXRX | EVP, Pharmaceutical Research | Option Exercise | 16,500 | — | — | Feb 28, 2014 |
| LXRX | EVP, Pharmaceutical Research | Option Exercise | 16,250 | — | — | Feb 28, 2013 |
| LXRX | EVP, Pharmaceutical Research | Tax Withholding | 12,537 | $2.11 | $26,453 | Jan 31, 2013 |
| LXRX | EVP, Pharmaceutical Research | Tax Withholding | 5,907 | $1.78 | $10,514 | Feb 28, 2012 |
| LXRX | EVP, Pharmaceutical Research | Option Exercise | 19,211 | $1.13 | $21,708 | Dec 22, 2011 |
| LXRX | EVP, Pharmaceutical Research | Award / Grant | 19,337 | — | — | Feb 23, 2011 |
| LXRX | EVP, Pharmaceutical Research | Tax Withholding | 7,314 | $1.91 | $13,970 | Feb 12, 2010 |
| LXRX | EVP, Pharmaceutical Research | Tax Withholding | 5,924 | $1.30 | $7,701 | Aug 12, 2009 |
| LXRX | EVP, Pharmaceutical Research | Award / Grant | 44,800 | — | — | Feb 12, 2009 |